Kobe Bio Medical Inovation Cluster
Japan
1 Mässor
Adress:
神戸市中央区加納町6-5-1
Om
The City of Kobe launched the Kobe Biomedical Innovation Cluster (KBIC) as a recovery project to rebuild
the economy of Kobe, which was severely damaged by the Great Hanshin-Awaji Earthquake that occurred
on January 17,1995. Since 1998, the City of Kobe has been endeavoring to develop an R&D hub for
advanced bio-medical technology on Port Island, an artificial island, and through collaboration with
industries, universities and medical institutions. To date, it has grown to become Japan's largest
biomedical cluster with a concentration of cutting-edge research institutes, highly specialized hospitals,
bio-medical and healthcare -related companies and universities. ■A concentration of more than 300 companies and organizations
・Research institutes, hospitals, and companies concentrated in a compact area; collaboration among them creates innovation
・A concentration of CROs, CMOs, and animal breeding and experimentation facilities responding to a variety of research and development
needs
・The Translational Research Informatics Center (TRI) supports clinical research; the medical cluster with eight highly specialized hospital
offers an excellent environment for clinical research
■Total support system
・Extensive support services for startups including a variety of incubation facilities and acceleration programs
・Kobe City staff, together with dedicated coordinators, provide support for commercialization,business expansion and matchmaking
・Strategic consultation on pharmaceutical affairs by PMDA is available
the economy of Kobe, which was severely damaged by the Great Hanshin-Awaji Earthquake that occurred
on January 17,1995. Since 1998, the City of Kobe has been endeavoring to develop an R&D hub for
advanced bio-medical technology on Port Island, an artificial island, and through collaboration with
industries, universities and medical institutions. To date, it has grown to become Japan's largest
biomedical cluster with a concentration of cutting-edge research institutes, highly specialized hospitals,
bio-medical and healthcare -related companies and universities. ■A concentration of more than 300 companies and organizations
・Research institutes, hospitals, and companies concentrated in a compact area; collaboration among them creates innovation
・A concentration of CROs, CMOs, and animal breeding and experimentation facilities responding to a variety of research and development
needs
・The Translational Research Informatics Center (TRI) supports clinical research; the medical cluster with eight highly specialized hospital
offers an excellent environment for clinical research
■Total support system
・Extensive support services for startups including a variety of incubation facilities and acceleration programs
・Kobe City staff, together with dedicated coordinators, provide support for commercialization,business expansion and matchmaking
・Strategic consultation on pharmaceutical affairs by PMDA is available
Mässdeltaganden
Japan Health
02.07.2027 - 04.07.2027 · Osaka, Japan
Hall: Hall6B
Booth: B-0702
